Triamcinolone-Induced Intraocular Pressure Elevation: Intravitreal Injection for Macular Edema and Posterior Subtenon Injection for Uveitis
Korean Journal of Ophthalmology
;
: 99-103, 2006.
Article
in English
| WPRIM
| ID: wpr-50102
ABSTRACT
PURPOSE:
To assess the effect of intravitreal and posterior subtenon injections of triamcinolone acetonide (TA) on intraocular pressure (IOP).METHODS:
we reviewed 42 consecutive eyes after intravitreal TA injection (IVTA) and 43 eyes following posterior subtenon TA injection (PSTA). All cases had a minimum follow-up time of three months. After injection, the value and time of the maximal IOP, the amount of IOP elevation and the needs of the medication were assessed.RESULTS:
The IOP increased significantly (p<0.001) from 16.3+/-2.5 mmHg preoperatively to a mean maximum of 21.7+/-5.3 mmHg in the IVTA group, and from 15.3+/-4.5 mmHg to 20.6+/-3.0 mmHg in the PSTA group. An elevation in the IOP of more than 5 mmHg from the baseline IOP was seen in 52.4% of the IVTA group at a mean time of 3.1 weeks postoperatively, and 44.2% of the PSTA group displayed an IOP elevation at 5.9 weeks.CONCLUSIONS:
Both developed significant elevations of IOP, but this appeared at a later date in the PSTA group. Careful follow-up after local injection of steroids is necessary.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Orbit
/
Time Factors
/
Vitreous Body
/
Triamcinolone Acetonide
/
Uveitis, Posterior
/
Macular Edema
/
Ocular Hypertension
/
Retrospective Studies
/
Follow-Up Studies
/
Glucocorticoids
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
English
Journal:
Korean Journal of Ophthalmology
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS